Clinical Trials Browser

Phase 2/3 × Interventional × Carcinoma × Clear all

NCT05063552 2026-03-18

Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT05050162 2026-03-03

Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer

Phase 2/3 Suspended

1,714 enrolled

Head & Neck

Carcinoma, Oropharyngeal Neoplasms

NCT03258554 2026-02-06

Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin

Phase 2/3 Completed

196 enrolled 31 charts

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT01554397 2024-11-29

Study With Intensity Modulated Radiation Therapy With Cisplatin to Treat Stage I-IVA Cervical Cancer

Phase 2/3 Completed

101 enrolled 13 charts

Gynecologic

Carcinoma, Uterine Cervical Neoplasms

NCT05144100 2021-12-03

SCOPE

Phase 2/3 Not yet recruiting

498 enrolled

Tumor-Agnostic

Carcinoma

NCT01149161 2016-04-21

Extent of Central Lymph Node Dissection in Papillary Thyroid Microcarcinoma

Phase 2/3 Unknown

2,000 enrolled

Head & Neck

Carcinoma, Thyroid Diseases

NCT01739465 2013-02-26

Comparison of Endoscopic Radiofrequency Ablation Versus Photodynamic Therapy for Inoperable Cholangiocarcinoma

Phase 2/3 Unknown

120 enrolled

Gastrointestinal

Adenocarcinoma, Bile Duct Diseases, Biliary Tract Diseases, Carcinoma, Constriction, Pathologic, Digestive System Diseases, Neoplasms, Neoplasms by Site, Cholangiocarcinoma

NCT00192712 2010-11-10

Irinotecan, Gemcitabine and Radiation Therapy for Pancreatic Cancer

Phase 2/3 Completed

20 enrolled

Gastrointestinal

Carcinoma, Pancreatic Neoplasms